GEGeraldine Engels

Geraldine Engels

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Geraldine Engels has a total of 94 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    High rates of viral co-detection in outpatient children with acute respiratory infections after the easing of preventive measures against Covid-19 in Germany

    by André Haufschild, Patricia Niekler, Johanna Sack, Benedikt Weissbrich, Kerstin Knies, Christoph Härtel, Andrea Streng, Lars Dölken, Johannes G. Liese, Geraldine Engels, et al.

    Background: Following the easing of preventive, non-pharmaceutical COVID-19 interventions (NPIs) during the late phase of the pandemic, acute respiratory infections (ARI) in children reemerged. We investigated the viral etiology, seasonality and clinical characteristics of children with ARI treated in primary care practices during this period. Methods: We conducted a prospective, observational study on children ≤ 14 years of age, presenting with acute upper (URTI) or lower (LRTI) ARI in five pediatric primary care practices in Wuerzburg, Germany, from 10/2021 to 05/2022. A maximum of eight children per practice were included on one predefined day per week. Oropharyngeal swabs were analyzed using (multiplex) PCR for 18 viral pathogens. Results: A total of 521 children (median age 3.3 years; IQR 1.6–5.5; 52% male) with ARI were enrolled (28% LRTI). At least one virus was detected in 85%, with human rhinovirus (HRV) (30%), Respiratory Syncytial Virus (RSV) (22%), and SARS-CoV-2 (16%) being the most frequent viruses. Co-detection (≥ 2 viruses) occurred in 156 (30%) patients, were most frequent in children < 2 years of age (38% of 164), and their rate decreased with increasing age ( p = 0.012). Bocavirus (88% of 56), adenovirus (80% of 48) and endemic coronaviruses (70% of 42) showed the highest proportion of co-detection. RSV and human metapneumovirus (hMPV) were predominant in LRTI, whereas HRV and SARS-CoV-2 were more prevalent in URTI. The LRTI rate was 32% of 288 mono-detections and 23% of 156 co-detection. Conclusions: During fall/winter 2021/2022, viral co-detection were common, possibly as a consequence of easing COVID-19-related NPIs, but were not associated with more severe clinical characteristics.


  • Influenza Influenza

    by Markus Knuf, Folke Brinkmann, Géraldine Engels, Johannes Forster, Ulrich Heininger, Johannes Liese, Andrea Streng, Walter H. Haas

  • Metapneumovirus-Infektionen

    by Anita Rack-Hoch, Géraldine Engels, Arne Simon, Johannes Liese

  • Open Access

    Influenza Immunization in Very-Low-Birth-Weight Infants: Epidemiology and Long-Term Outcomes

    by Marie-Theres Dammann, Hannah Kraft, Guido Stichtenoth, Kathrin Hanke, Michael Zemlin, Janina Soler Wenglein, Isabell Ricklefs, Alexander Herz, Alexander Humberg, Dorothee Viemann, et al.

    Background: Very-low-birth-weight infants (VLBWIs; birth weight < 1500 g) are at an increased risk of complicated influenza infection, which frequently includes pneumonia, encephalitis or even death. Data on influenza immunization and its outcome in VLBWIs are scarce. This study aimed to provide epidemiological data on influenza immunization for German VLBWIs and hypothesized that immunization would protect VLBWIs from infection-mediated neurodevelopmental impairment and preserves lung function at early school age. Methods: In this observational population-based German Neonatal Network (GNN) study, infants born between 2009 and 2015 were invited to partake in a 6-year follow-up investigation including lung function and developmental testing. Uni- and multivariate analyses were performed to evaluate the clinical characteristics and outcomes of influenza-immunized VLBWIs compared to non-immunized VLBWIs. Results: Influenza immunization was performed in 871 out of the 3358 VLBWIs (26%) with six-year follow-up. Immunized infants were characterized by a low gestational age and higher rates of morbidity, particularly bronchopulmonary dysplasia. Although early immunization showed no safety signals and had protective effects on the long-term risk of bronchitis (OR: 0.2; CI: 0.1–0.6; p = 0.002), most VLBWIs (88.0%) were unimmunized in their first influenza season. Conclusions: Influenza immunization was not associated with improved lung function (forced expiratory volume in one second and forced vital capacity) or a better neurocognitive outcome (intelligence quotient and strengths and difficulties questionnaire) at early school age. In Germany, only one quarter of 6-year-old VLBWIs were immunized against influenza, particularly those born <28 gestational weeks and/or BPD. Specific influenza immunization guidelines that define evidence-based recommendations are needed for this vulnerable group.


  • Clinical accuracy of SARS-CoV-2 rapid antigen testing in screening children and adolescents

    by Manuel Krone, Isabell Wagenhäuser, Kerstin Knies, Daniela Hofmann, Geraldine Engels, Regina Taurines, Miriam McDonogh, Sven Flemming, Thomas Meyer, Hartmut Böhm, et al.


  • Open Access

    Clinical accuracy of SARS-CoV-2 rapid antigen testing in screening children and adolescents in comparison to RT-qPCR, November 2020 to September 2022

    by Manuel Krone, Isabell Wagenhäuser, Kerstin Knies, Daniela Hofmann, Geraldine Engels, Regina Taurines, Miriam McDonogh, Sven Flemming, Thomas Meyer, Hartmut Böhm, et al.

    Background: Rapid antigen detection tests (RDT) are an easily accessible, feasible, inexpensive, and point-of-care method in SARS-CoV-2 diagnostics – established in adults as well as in children and adolescents. Despite this, large-scale data of clinical performance in the paediatric population especially regarding the influence of SARS-CoV-2 virus variants of concern (VOC) and COVID-19 vaccination on test accuracy is rare. Methods: This single-centre prospective diagnostic study evaluates three RDT (NADAL®, Panbio™, MEDsan®) in comparison to quantitative reverse transcription polymerase chain reaction (RT-qPCR). 9,760 oropharyngeal screening samples regarding SARS-CoV-2 VOC and COVID-19 vaccination in paediatric hospitalised patients aged younger than 18 years were enrolled. Findings: RDT sensitivity was 44·7% (157/351, 95% CI 39·6%–50·0%) compared to the reference standard RT-qPCR, specificity 99·8% (9,392/9,409, 95% CI 99·7%–99·9%). Most SARS-CoV-2 infections considered were caused by Omicron VOC. Diagnostic accuracy of RDT depended on specimen containing viral load with a decreasing RDT sensitivity by descending viral load, corresponding with a significantly impaired sensitivity in asymptomatic children. A sensitivity of 71·0% was obtained for a viral load higher than 10 6 SARS-CoV-2 RNA copies per ml suggested as infectivity threshold. No significant differences in RDT sensitivity could be observed regarding gender, symptoms, COVID-19 vaccination status, and VOC. Interpretation: In a paediatric population, RDT have proven to reliably detect potentially highly infectious patients with a viral load of at least 10 6 SARS-CoV-2 RNA copies per ml. Due to the low sensitivity in asymptomatic individuals, the usefulness of RDT seems limited in large-scale SARS-CoV-2 screening programs. Funding: Federal Ministry for Education and Science (BMBF), Free State of Bavaria

  • Open Access

    Maternal versus paternal living kidney transplant donation is associated with lower rejection in young pediatric recipients: A Collaborative Transplant Study report

    by Geraldine Engels, Bernd Döhler, Burkhard Tönshoff, Jun Oh, Anne Kruchen, Ingo Müller, Caner Süsal

    Background: Approximately 1700 children per year with end‐stage kidney disease undergo kidney transplantation in Europe and the United States of America; 30%–50% are living donor kidney transplantations. There may be immunological differences between paternal and maternal donors due to transplacental exchange of cells between the mother and fetus during pregnancy leading to microchimerism. We investigated whether the outcome of living‐related kidney transplantation in young children is different after maternal compared with paternal organ donation.Methods: Using the international Collaborative Transplant Study (CTS) database, we analyzed epidemiological data of 7247 children and adolescents aged N = 195) during the first 2 years post‐transplant was significantly lower (hazard ratio HR = 0.47, p = .004) than in patients receiving kidneys from paternal donors (N = 179). This association between donor sex and risk of treated rejections was not observed in children aged 5–9 years. The 5‐year death‐censored graft survival in children aged 1–4 years with a maternal or paternal donor was comparable.Conclusions: Maternal kidney donation in young pediatric renal transplant recipients is associated with an approximately 50% lower rate of treated rejection than paternal kidney donation. Whether this phenomenon is due to maternal microchimerism‐induced donor‐specific hyporesponsiveness must be evaluated in prospective mechanistic studies.


  • Open Access

    Five Year Follow Up of Extremely Low Gestational Age Infants after Timely or Delayed Administration of Routine Vaccinations

    by Ingmar Fortmann, Marie-Theres Dammann, Alexander Humberg, Bastian Siller, Guido Stichtenoth, Geraldine Engels, Janina Marißen, Kirstin Faust, Kathrin Hanke, Sybelle Goedicke-Fritz, et al.

    This study is aimed at detecting the rate of untimely immunization in a large cohort of extremely low gestational age neonates (ELGANs) of the German Neonatal Network (GNN) and at addressing risk factors for delayed vaccination and associated long-term consequences. We performed an observational study of the GNN between 1st January 2010 and 31st December 2019. The immunization status for the hexavalent and pneumococcal immunization was evaluated in n = 8401 preterm infants n = 824 (9.8%) ELGANs did not receive a timely first immunization with the hexavalent and pneumococcal vaccine. Risk factors for delayed vaccination were SGA status (18.1% vs. 13.5%; OR 1.3; 95% CI: 1.1–1.7), impaired growth and surrogates for complicated clinical courses (i.e., need for inotropes, necrotizing enterocolitis). At 5 years of age, timely immunized children had a lower risk of bronchitis (episodes within last year: 27.3% vs. 37.7%; OR 0.60, 95% CI: 0.42–0.86) but spirometry measures were unaffected. In conclusion, a significant proportion of ELGANs are untimely immunized, specifically those with increased vulnerability, even though they might particularly benefit from the immune-promoting effects of a timely vaccination.